Power mobility device, not coded by dme pdac or does not meet criteria
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies. Given that macroautophagy…
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor prognosis. Insights into the roles of MicroRNAs…
Objective Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive type of GI tumour, and it possesses deregulated cellular…
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, and early diagnosis and assessment may enhance…
The present study aimed to determine the clinical significance and potential molecular mechanisms of C-C motif chemokine receptor…
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by poor survival despite current medical and surgical…
The aim of the study was to evaluate the feasibility of a longitudinal non-invasive monitoring of rat pancreatic ductal…
Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease with a poor prognosis and targeted therapies have failed in the…